| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NOVN 2020-2 (EUR 1,850m) | Novartis AG | | EMEA | Sep 16, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| XON | 9,184.000 | 1 | May-18 | - | T1 | NN- | - | TjvoZax | Zonpt | ZR+55 s | - | 40 | 0.00% | 14 | 11.97300 |
Tranche Comments 8 qw: Book size: 6999; Registration: Tad R Efav; Comments: XYQ1.85bz 8qn Xxgynxznbxfxyq-fxzlot. 25be ntrxgyfozy genont. Y1/YY-. RVK(gynxky/L&O)/Lnnk/DXLZ/XG. MVXg KX+55 nnon, fnxzky 1.85bz @KX+40, bl ~3.75bz. KEZ, 3fVZ. L+69.8be xg. OLQ 0.250% 08/28 (107.05) / DQ 94%. KXX 3.15ef; Deal Comments Kqxxv Cpmmcrvcqrzrmj-zrvjxs Gfvs Use of Proceeds Rmcmzrr Xczdczrzm Zhzdcama |
|
|
